$ACUT
Accustem Sciences Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224046438 Filed on November 18, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $31.41K
YoY Change 57.43%
% of Gross Profit
Depreciation & Amortization $907.00
YoY Change 0.0%
% of Gross Profit
Operating Expenses $328.2K
YoY Change -45.17%
Operating Profit -$328.2K
YoY Change -45.17%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$328.2K
YoY Change -45.17%
Income Tax
% Of Pretax Income
Net Earnings -$328.2K
YoY Change -45.17%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03
COMMON SHARES
Basic Shares Outstanding 11.35M shares 11.35M shares
Diluted Shares Outstanding 11.35M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $37.08K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $65.41K
Receivables
Other Receivables
Total Short-Term Assets $102.5K
YoY Change -59.43%
LONG-TERM ASSETS
Property, Plant & Equipment $1.325K
YoY Change -73.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.325K
YoY Change -73.26%
TOTAL ASSETS
Total Short-Term Assets $102.5K
Total Long-Term Assets $1.325K
Total Assets $103.8K
YoY Change -59.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $790.2K
YoY Change 82.77%
Accrued Expenses $164.1K
YoY Change -64.76%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.297M
YoY Change 53.87%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.297M
Total Long-Term Liabilities
Total Liabilities $3.297M
YoY Change 53.87%
SHAREHOLDERS EQUITY
Retained Earnings -$7.655M
YoY Change 21.97%
Common Stock $11.35K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.194M
YoY Change
Total Liabilities & Shareholders Equity $103.8K
YoY Change -59.69%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$328.2K
YoY Change -45.17%
Depreciation, Depletion And Amortization $907.00
YoY Change 0.0%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-328174 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1133001 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1804622 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 us-gaap Cash
Cash
37080 usd
CY2023Q4 us-gaap Cash
Cash
21481 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
65414 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
108368 usd
us-gaap Net Income Loss
NetIncomeLoss
-1133001 usd
us-gaap Net Income Loss
NetIncomeLoss
-1804622 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
55679 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2245477 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
11346 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19951 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96352 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50128 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
578574 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1036649 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1754494 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
598525 usd
us-gaap Operating Expenses
OperatingExpenses
1133001 usd
us-gaap Operating Expenses
OperatingExpenses
1804622 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-598525 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1133001 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1804622 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
49500 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-46960 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1320612 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
940665 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
283021 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
657644 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-662968 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
733978 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
71010 usd
us-gaap Notes Issued1
NotesIssued1
372879 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11346535 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11346535 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11346535 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11346535 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11346535 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11346535 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
636086 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001850767
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
ACUT Amendment Of Issuance Of Note Payable For Payment Of Prepaid Expense
AmendmentOfIssuanceOfNotePayableForPaymentOfPrepaidExpense
usd
CY2024Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56257
dei Entity Registrant Name
EntityRegistrantName
ACCUSTEM SCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3774438
dei Entity Address Address Line1
EntityAddressAddressLine1
5 Penn Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
19th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
#1954 New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
dei City Area Code
CityAreaCode
00 44
dei Local Phone Number
LocalPhoneNumber
2074952379
dei Security12g Title
Security12gTitle
Common Stock
dei Trading Symbol
TradingSymbol
ACUT
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11346535 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Assets Current
AssetsCurrent
102494 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
129849 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1325 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4048 usd
CY2024Q3 us-gaap Assets
Assets
103819 usd
CY2023Q4 us-gaap Assets
Assets
133897 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
790241 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
578378 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2285562 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1454986 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
164053 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
156434 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
57597 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3297453 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3297453 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2245477 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11346535 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11346535 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11346535 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11346535 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
11346 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4449966 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4399019 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7654946 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6521945 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3193634 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2111580 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103819 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133897 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31409 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
296765 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
328174 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-328174 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-598525 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1133001 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1804622 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-328174 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-598525 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11346535 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11346535 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11346535 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11346535 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11346535 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11346535 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11346535 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11346535 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-2884306 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18846 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-328174 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3193634 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1306812 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19900 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-598525 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1885437 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2111580 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
50947 usd
us-gaap Net Income Loss
NetIncomeLoss
-1133001 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3193634 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-139550 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-139550 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58735 usd
us-gaap Net Income Loss
NetIncomeLoss
-1804622 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1885437 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1885437 usd
us-gaap Net Income Loss
NetIncomeLoss
-1133001 usd
us-gaap Net Income Loss
NetIncomeLoss
-1804622 usd
us-gaap Depreciation
Depreciation
2723 usd
us-gaap Depreciation
Depreciation
2723 usd
us-gaap Share Based Compensation
ShareBasedCompensation
50947 usd
us-gaap Share Based Compensation
ShareBasedCompensation
58735 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-145869 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-269880 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-29603 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
211863 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
120529 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
49499 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7620 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-664480 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
781077 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
100998 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
680079 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15599 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21481 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37080 usd
us-gaap Notes Issued1
NotesIssued1
102915 usd
ACUT Amendment Of Issuance Of Note Payable For Payment Of Prepaid Expense
AmendmentOfIssuanceOfNotePayableForPaymentOfPrepaidExpense
-89818 usd
us-gaap Interest Paid Net
InterestPaidNet
2560 usd
us-gaap Interest Paid Net
InterestPaidNet
4278 usd
us-gaap Net Income Loss
NetIncomeLoss
-1133001 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7654946 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_z54gVBAlDgr" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z2KAuzClA8Nf">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10999 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10999 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9674 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6951 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1325 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4048 usd
CY2024Q3 us-gaap Depreciation
Depreciation
907 usd
CY2023Q3 us-gaap Depreciation
Depreciation
907 usd
us-gaap Depreciation
Depreciation
2723 usd
us-gaap Depreciation
Depreciation
2723 usd
CY2024Q3 ACUT Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
146594 usd
CY2023Q4 ACUT Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
146594 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17459 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9840 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
164053 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
156434 usd
us-gaap Foreign Currency Translation Adjustment Description
ForeignCurrencyTranslationAdjustmentDescription
converted from EUROS to USD using exchange rate of €1:$1.076247
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-328174 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-598525 usd
us-gaap Net Income Loss
NetIncomeLoss
-1133001 usd
us-gaap Net Income Loss
NetIncomeLoss
-1804622 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-328174 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-598525 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11346535 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11346535 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
636086 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1611115 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1611115 shares
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
636086 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1611115 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
636086 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1611115 shares
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
118846 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19900 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50947 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
58735 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0180 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5343 pure
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
790586 usd

Files In Submission

Name View Source Status
0001493152-24-046438-index-headers.html Edgar Link pending
0001493152-24-046438-index.html Edgar Link pending
0001493152-24-046438.txt Edgar Link pending
0001493152-24-046438-xbrl.zip Edgar Link pending
acut-20240930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
acut-20240930_cal.xml Edgar Link unprocessable
acut-20240930_def.xml Edgar Link unprocessable
acut-20240930_pre.xml Edgar Link unprocessable
acut-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending